This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2002 Nov;60(10):383-8.

Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis

W J van Venrooij¹, J M Hazes, H Visser

Affiliations

PMID: 12607587

Free article

Review

Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis

W J van Venrooij et al. Neth J Med. 2002 Nov.

Free article

. 2002 Nov;60(10):383-8.

Authors

W J van Venrooij¹, J M Hazes, H Visser

Affiliation

¹ Department of Biochemistry (161), University of Nijmegen, PO Box 9101, 6500 HB Nijmegen, the Netherlands. W.vanVenrooij@ncmls.kun.nl

PMID: 12607587

No abstract available

PubMed Disclaimer

Comment in

Are prognostic factors in rheumatoid arthritis of any use in daily clinical practice?
van Riel P. van Riel P. Neth J Med. 2002 Nov;60(10):381-2. Neth J Med. 2002. PMID: 12607586 No abstract available.

Similar articles

Are prognostic factors in rheumatoid arthritis of any use in daily clinical practice?
van Riel P. van Riel P. Neth J Med. 2002 Nov;60(10):381-2. Neth J Med. 2002. PMID: 12607586 No abstract available.
[Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].
Bas S. Bas S. Rev Med Suisse. 2005 Mar 9;1(10):674, 677-8, 680 passim. Rev Med Suisse. 2005. PMID: 15828370 Review. French.
[Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis].
Yalaoui S. Yalaoui S. Arch Inst Pasteur Tunis. 2006;83(1-4):13-7. Arch Inst Pasteur Tunis. 2006. PMID: 19388592 Review. French.
[New diagnostic tests for rheumatoid arthritis].
Hayashi N, Kumagai S. Hayashi N, et al. Rinsho Byori. 2003 Oct;51(10):1030-5. Rinsho Byori. 2003. PMID: 14653204 Review. Japanese.
[New biomarkers for rheumatoid arthritis].
Hayashi N, Nishimura K, Kumagai S. Hayashi N, et al. Rinsho Byori. 2008 Apr;56(4):297-308. Rinsho Byori. 2008. PMID: 18516964 Review. Japanese.

See all similar articles

Cited by

Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study.
Atzeni F, Sarzi-Puttini P, Dell' Acqua D, de Portu S, Cecchini G, Cruini C, Carrabba M, Meroni PL. Atzeni F, et al. Arthritis Res Ther. 2006;8(1):R3. doi: 10.1186/ar1851. Arthritis Res Ther. 2006. PMID: 16356192 Free PMC article. Clinical Trial.
The association of anti-CCP antibodies with disease activity in rheumatoid arthritis.
Serdaroğlu M, Cakirbay H, Değer O, Cengiz S, Kul S. Serdaroğlu M, et al. Rheumatol Int. 2008 Aug;28(10):965-70. doi: 10.1007/s00296-008-0570-3. Epub 2008 Apr 17. Rheumatol Int. 2008. PMID: 18418600 Free PMC article.
Complement in the Initiation and Evolution of Rheumatoid Arthritis.
Holers VM, Banda NK. Holers VM, et al. Front Immunol. 2018 May 28;9:1057. doi: 10.3389/fimmu.2018.01057. eCollection 2018. Front Immunol. 2018. PMID: 29892280 Free PMC article. Review.
Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement.
Alessandri C, Bombardieri M, Papa N, Cinquini M, Magrini L, Tincani A, Valesini G. Alessandri C, et al. Ann Rheum Dis. 2004 Oct;63(10):1218-21. doi: 10.1136/ard.2003.014647. Ann Rheum Dis. 2004. PMID: 15361374 Free PMC article. Clinical Trial.
Immune recognition of citrullinated epitopes.
Nguyen H, James EA. Nguyen H, et al. Immunology. 2016 Oct;149(2):131-8. doi: 10.1111/imm.12640. Epub 2016 Aug 17. Immunology. 2016. PMID: 27531825 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- van Zuiden Communications
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information